Ukko
Vision
Improve the lives of the millions that suffer from food allergies and sensitivities.
Approach
Ukko uses immunology, machine learning and protein engineering to make measurably better and safer proteins for treating allergies. Ukko does this by designing and controlling the molecular interactions between allergen proteins and the immune system.
Ukko’s technology uses samples from patients and machine learning to guide the engineering of superior proteins that can cure allergy and prevent reactions in people with sensitivities. These proteins maintain or improve beneficial properties but do not trigger an allergic reaction. Ukko’s initial product pipeline includes peanut proteins for the next generation of allergy immunotherapy.